770 Subject Index
third cerebral ventricle 556
TNF-α 397, 398, 401, 403
tolerance 455, 583, 592, 693–698
Tourette’s syndrome 491, 498, 728
trachea 347
transforming growth factor 398
transient receptor potential (TRP)
ion channel
seeANKTM1
seeTRPV1 receptor(s)
transmembranecarrierprotein 188
tremor 723
Trichomonas vaginalis 402
trophoblasts 566
TRPV1 receptor(s) 6, 22, 26, 27, 37,
148, 156, 158, 161, 163, 164,
166–168, 293, 369, 377, 432,
462, 484, 485, 487, 498, 499,
561, 574, 582, 588–592, 608,
609, 613, 615, 618
agonists 484
antagonists 484, 487
in the basal ganglia 488, 495
TRPV1-like receptors 29
Trypanosome brucei 413
tumor necrosis factor 392
tumoricidal activity 392
Tyr kinase 58
UCM-119 200
UCM-707 200
UCM707 (N-(3-furylmethyl)arachi-
donoylamine) 199
ulceration 592
URB597 192, 193, 197
urinary bladder 345, 347, 351
urine 677, 678
urochordate(s) 285, 290, 291
uterus 564
vanilloid receptor(s)
seeTRPV1 receptor(s)
vas deferens 11, 35, 37, 345, 346,
351
vasodilation 605–612, 617
VDM 11 (N-(4-hydroxy-2-methyl-
phenyl)arachidono-
ylamine) 199, 200
ventral horn 318
ventral pallidum 311
ventral tegmental area 314, 332,
333, 337, 338
ventral tegmentum 313
vertebrate 285, 286, 289, 291, 294
vertebrates 290
vesicle release machinery
350, 356
virodhamine 5, 14, 17, 18, 190, 196
virus 289
voltage-dependent calcium channels
329, 349, 356
voltage-dependent sodium channels
330
voltage-gated Ca2+-channels 59
voltage-gated ion channels 329
VR1 seeTRPV1 receptor(s)
VR1 receptor
seeTRPV1 receptor(s)water maze 451
water-soluble cannabinoid 20
WIN55212-2
see R-(+)-WIN55212(^133) Xe 430
Xenopus laevis 285
zif268 62
Zucker rats 560